Skip to main content
SpringerLink
Log in

Markers and Immunoprofile of Fibroblastic, Myofibroblastic, and Fibrohistiocytic Tumors

  • Chapter
  • First Online:
Book cover Immunohistochemistry in Tumor Diagnostics

  • 2757 Accesses

Abstract

Vimentin, actin, desmin, CD34, and CD68

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Robinson DR, Wu Y-M, Kalyana-Sundaram S. Identification of recurrent NAB2-STAT6 gene vfusion in solitary fibrous tumor. Nat Genet. 2013;45(2):180–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Vogels R, Vlenterie M, Versleijen-Jonkers Y, et al. Solitary fibrous tumor—clinicopathologic, immunohistochemical and molecular analysis of 28 cases. Diagn Pathol. 2014;9:224.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Barthelmess S, Geddert H, Boltze C, et al. Solitary fibrous tumor/hemangiopericytoma with different variants of the NAB2-STAT6 gene fusion are characterized by specific histomorphology and distinct clinicipathological features. Am J Pathol. 2014;184(4):1209–18.

    Article  CAS  PubMed  Google Scholar 

  4. Demicco EG, Harms PW, Patel RM, et al. Extensive survey of STAT6 expression in large series of mesenchymal tumors. Am J Clin Pathol. 2015;143:672–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Doyle LA, Vivero M, Fletcher CH, et al. Nuclear expression of STAT6 distinguishes solitary fibrous tumor from histologic mimics. Mod Pathol. 2014;27(3):390–5.

    CAS  PubMed  Google Scholar 

  6. Doyle LA, Möller E, Dal Cin P, et al. MUC4 is a highly sensitive and specific marker for low grade fibromyxoid sarcoma. Am J Surg Pathol. 2011;35(5):733–41.

    Article  PubMed  Google Scholar 

  7. Doyle A, Wang WL, Dal Cin P, et al. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am J Surg Pathol. 2012;36(10):1444–51.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Carl-Thiem-Klinikum, Institut für Pathologie, Cottbus, Germany

    Muin S. A. Tuffaha

  2. Vivantes Klinikum Neukölln, Institut für Pathologie, Berlin, Germany

    Hans Guski

  3. Universität Bonn, UKB, Institut für Pathologie, Bonn, Germany

    Glen Kristiansen

Authors
  1. Muin S. A. Tuffaha
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Guski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Glen Kristiansen
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Tuffaha, M.S.A., Guski, H., Kristiansen, G. (2018). Markers and Immunoprofile of Fibroblastic, Myofibroblastic, and Fibrohistiocytic Tumors. In: Immunohistochemistry in Tumor Diagnostics. Springer, Cham. https://doi.org/10.1007/978-3-319-53577-7_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-53577-7_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-53576-0

  • Online ISBN: 978-3-319-53577-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation